Statistics for MiMedx Group, (id:5343 MDXG)

Valuation metrics

Market cap

1.34B

Enterprise value

1.29B

Trailing P/E (ttm)

16.04

Forward P/E

29.48

PEG ratio

29.48

Price/Sales (ttm)

3.92

Price/Book (mrq)

7.42

Enterprise Value/Revenue

3.77

Enterprise Value/EBITDA

19.17

Overview

Shares outstanding

146.95M

Float

108.98M

Shares short

4.00M

% Held by insiders

0.02%

% Held by institutions

0.68%

Average volume (10 days)

1.44M

Average volume (90 days)

Price summary

52-Week low

5.47

52-Week high

9.49

52-Week change

16.74%

Beta

1.94

50-Day moving average

6.30

200-Day moving average

6.99

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

April 02th, 2008

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

25.80%

Operating margin

13.63%

Operational effectiveness

Return on assets

18.38%

Return on equity

62.47%

Income statement

Revenue (ttm)

2.45

Revenue per share (ttm)

2.45

Quarterly revenue growth (yoy)

-0.05

Gross profit (ttm)

266.84M

EBITDA

75.66M

Net income to common (ttm)

79.39M

Diluted EPS (ttm)

0.57

Quarterly earnings growth (yoy)

-5.10%

Balance sheet

Total cash (mrq)

88.80M

Total cash per share (mrq)

0.60

Total debt (mrq)

19.02M

Total Debt/Equity (mrq)

10.51

Current ratio (mrq)

410.40%

Book value per share (mrq)

1.23

Cash flow

Cash flow statement

57.67M

Levered free cash flow (LFCF)

45.83M